文献速递白内障与屈光手术

针对白内障人工晶状体植入成人患者的视觉症状特异性患者报告结局量表的开发与验证

Development and Validation of a Visual Symptom-Specific Patient-Reported Outcomes Instrument for Adults With Cataract Intraocular Lens Implants.
PubMed 文献 · Am J Ophthalmol · 2021-11-03

本研究开发并验证了视觉干扰问卷(QUVID),用于评估白内障患者植入单焦点、传统多焦点或三焦点人工晶状体前后的视觉与眼部症状。QUVID涵盖7种视觉症状的困扰程度及术后是否因症状希望再次手术,经美国、加拿大、澳大利亚150例横断面研究和457例美国临床试验验证,并由美国食品药品监督管理局审评认为适合作为用途匹配的测量工具。

要点

  • QUVID包含7种视觉症状(星芒、光晕、眩光、雾视、模糊、复视、暗区)的困扰程度评估。
  • 术后版本包含1个条目,询问若人工晶状体是原因,症状是否困扰到希望再次手术。
  • QUVID经美国食品药品监督管理局审评,认为内容效度、结构效度、信度和检测变化能力证据充分。

核心结论

  • QUVID经美国食品药品监督管理局审评,认为适合作为用途匹配的测量工具,具备内容效度、结构效度、信度和检测变化能力的必要证据。

研究设计与样本

  • 问卷开发与验证研究:基于文献和工具综述、美国与欧洲13名眼科医生访谈、美国与澳大利亚67例成人患者的混合定性访谈开发QUVID。
  • 通过美国、加拿大、澳大利亚150例既往治疗白内障患者的非干预横断面研究评估心理测量学特性。
  • 通过2项美国关键临床试验(三焦点或扩展视力人工晶状体与单焦点人工晶状体对照,n=457)评估检测有意义变化的能力。

主要发现

  • QUVID包含关于7种视觉症状困扰程度的子条目:星芒、光晕、眩光、雾视、模糊、复视和暗区。
  • 术后版本包含1个条目,询问受访者若人工晶状体是原因,症状是否困扰到希望再次手术。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To develop a patient-reported outcome measure for capturing visual and ocular symptoms before and after implantation of intraocular lenses (IOLs) for treatment of cataracts. DESIGN: Questionnaire development and validation study. METHODS: The Questionnaire for Visual Disturbances (QUVID) was developed based on a literature and instrument review; 13 clinician interviews among ophthalmologists in the United States and Europe; and 67 hybrid qualitative patient interviews among adult patients in the United States and Australia before and/or after monofocal, traditional multifocal, or trifocal IOL implantation. Assessment of the QUVID's psychometric properties was conducted via a noninterventional cross-sectional study of previously treated cataract patients in the United States, Canada, and Australia (n = 150), and assessment of ability to detect meaningful change via 2 pivotal US clinical trials among patients with trifocal or extended vision IOL compared with monofocal IOL controls (n = 457). RESULTS: The QUVID includes subitems about the bothersomeness of 7 visual symptoms: starburst, halo, glare, hazy vision, blurred vision, double vision, and dark areas. The postoperative version contains 1 item asking the respondents whether their symptoms bothered them enough to want another surgery, if the IOL was the cause. CONCLUSIONS: The QUVID was reviewed by the US Food and Drug Administration and found appropriate as a fit-for-purpose measure, demonstrating requisite evidence for content validity, construct validity, reliability, and ability to detect change.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Lasch K, Marcus JC, Seo C, et al. Development and Validation of a Visual Symptom-Specific Patient-Reported Outcomes Instrument for Adults With Cataract Intraocular Lens Implants. Am J Ophthalmol. 2021. PMID: 34740627. doi:10.1016/j.ajo.2021.10.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。